in a randomized , controlled study 10 male patients with angiographically confirmed ischaemic heart disease received aq-a 39 ( falipamil ) , a heart rate reducing agent in a single intravenous dose ( 2 mg kg-1 ) in comparison to propranolol ( 0.1 mg kg-1 ) .
C0428977
heart rate
C0033497
propranolol